The Latest Cardiac and Vascular News
PARIS, May 21, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced key events for the company during EuroPCR 2018, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of […]
IRVINE, Calif., May 21, 2018 /PRNewswire/ — CERENOVUS, part of the Johnson & Johnson Medical Devices Companies, announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EMBOTRAP II Revascularization Device, a next generation stent retriever used to capture and remove life-threatening blood clots from […]
EDEN PRAIRIE, Minn., May 17, 2018 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq:CHFS), today announces that it will be exhibiting at the Heart Failure Meeting from May 26-29, 2018 in Vienna, Austria. This annual congress is organized by the Heart Failure Association of the European Society of Cardiology and draws approximately […]
Contributed by Steve Henao, MD A very pleasant, active 75-year-old patient at our hospital received the disturbing news last July that she had an 80 percent blockage in one of her two carotid arteries, a diagnosis known as carotid artery disease. She was concerned about the risk of treatment and […]
TORONTO, May 17, 2018 (GLOBE NEWSWIRE) — CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for acute and chronic cardiovascular conditions, today announced completion of patient enrollment in a large scale, investigator sponsored trial (“CONDI 2”) to further assess […]
VANCOUVER, May 17, 2018 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., today announced that its partner Eddingpharm has enrolled the first patient in a randomized, double-blind, placebo-controlled, Phase 3 clinical study evaluating Brinavess® versus placebo in patients with recent onset atrial fibrillation (AF). Approximately 240 patients are expected […]
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care, urology and surgery, coronary and peripheral interventions, will showcase its complex PCI product portfolio and the Arrow® AC3 Optimus™ Intra-Aortic Balloon Pump (IABP) at the EuroPCR being held in Paris, France on May 22 – […]
LAGUNA HILLS, Calif., May 16, 2018 /PRNewswire/ — NeuroVasc Technologies, Inc., a medical device company active in the endovascular field, announced today that it has closed a $6.3MM Series B Preferred Stock financing. The funding includes multiple investors and was led by ShangBay Capital. NeuroVasc Technologies, Inc. is dedicated to improving treatment of […]
CHARLOTTESVILLE, Va., May 16, 2018 /PRNewswire/ — CareTaker Medical, LLC, an innovator in Continuous Non-Invasive Blood Pressure and wireless Vital Signs monitoring today announced completion of a $3.4M investment round led by IrishAngels, KOFA Healthcare and Jaffray Woodriff (executed by his family office, Felton Group, LLC), with participation from both new and existing individual investors. Proceeds will accelerate the […]
THOUSAND OAKS, Calif., May 16, 2018 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has approved a new indication in the Repatha® (evolocumab) label for adults with established atherosclerotic cardiovascular disease (myocardial infarction, stroke or peripheral arterial disease) to reduce cardiovascular risk by lowering low-density lipoprotein cholesterol (LDL-C) levels. With the […]
